Rapid Medical Diagnostic Kits Market to Surpass $26 Billion with 4% CAGR by 2034 | Fact.MR Analysis
17 oct. 2024 07h00 HE
|
FACT.MR
Rockville, MD, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fact.MR, a market research and competitive intelligence provider, reveals in its updated research report that the global rapid medical diagnostic kit...
Trichomonas Rapid Testing Market Projected to Grow to $761.9 Million by 2034 | Fact.MR Report
08 oct. 2024 07h30 HE
|
FACT.MR
Rockville, MD, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Fact.MR recently published a new report stating the global Trichomonas rapid testing market is estimated to reach a valuation of US$ 467.7 million in...
India Rapid Test Kit Market to Grow by $200 Million During 2024-2030: Assessment of Emerging Trends, Opportunities, Segments, and Major Players
04 oct. 2024 05h15 HE
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "India Rapid Test Kit Market, By Region, Competition, Forecast and Opportunities 2020-2030F" report has been added to ResearchAndMarkets.com's...
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
27 juin 2024 09h00 HE
|
bioLytical Laboratories Inc.
bioLytical helps boost testing with free HIV rapid test donations to KFF and the Greater Than HIV campaign to support national testing efforts
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
19 mai 2024 18h00 HE
|
bioLytical Laboratories Inc.
bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)
Point-of-Care Diagnostics Market to be Worth $43.1 Billion by 2030 - Exclusive Report by Meticulous Research®
23 mai 2023 10h00 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, May 23, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis,...
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
27 mars 2023 08h00 HE
|
bioLytical Laboratories Inc.
bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test across Canada for professional use in point-of-care settingsBy providing results for two...
Global HIV Rapid Test Kits Market Outlook Report 2023: A $1.68 Billion Market by 2028 Featuring Key Vendors - Abbott, Bio-Rad Laboratories, BIOMERIEUX, Chembio Diagnostics, & OraSure Technologies
10 févr. 2023 09h53 HE
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "HIV Rapid Test Kits Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global HIV...
bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test
01 avr. 2022 20h00 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today that it is launching a second test on its new platform, iStatis, after receiving Health Canada authorization for the iStatis COVID-19 Antigen Home Test for...
bioLytical Laboratories Inc. Receives Health Canada Authorization for its iStatis COVID-19 Antigen Test
07 mars 2022 09h00 HE
|
bioLytical Laboratories Inc.
From the makers of INSTI®, bioLytical launches a new platform, iStatis, created to ensure every person in the world has access to reliable testingbioLytical has received Health Canada authorization to...